GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 151 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,050,000 | -61.4% | 43,953 | -76.4% | 0.08% | -59.2% |
| Q4 2020 | $2,721,000 | +28.0% | 186,371 | +24.5% | 0.18% | +31.4% |
| Q3 2020 | $2,126,000 | -26.4% | 149,717 | -23.7% | 0.14% | -28.6% |
| Q2 2020 | $2,887,000 | +1171.8% | 196,240 | +256.2% | 0.20% | +988.9% |
| Q1 2020 | $227,000 | +11.3% | 55,100 | +29.6% | 0.02% | +38.5% |
| Q4 2019 | $204,000 | -6.4% | 42,500 | +18.1% | 0.01% | 0.0% |
| Q3 2019 | $218,000 | -6.8% | 36,000 | 0.0% | 0.01% | -7.1% |
| Q2 2019 | $234,000 | -8.2% | 36,000 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $255,000 | +15.4% | 36,000 | -20.7% | 0.01% | +16.7% |
| Q4 2018 | $221,000 | -14.3% | 45,400 | +29.3% | 0.01% | +9.1% |
| Q3 2018 | $258,000 | +10.7% | 35,121 | +18.8% | 0.01% | +120.0% |
| Q3 2015 | $233,000 | +65.2% | 29,569 | +117.4% | 0.01% | +25.0% |
| Q2 2013 | $141,000 | – | 13,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versor Investments LP | 2,664,831 | $63,689,000 | 3.80% |
| Chicago Capital Management, LLC | 318,113 | $7,603,000 | 3.54% |
| First Trust Capital Management L.P. | 564,758 | $13,498,000 | 2.64% |
| WATER ISLAND CAPITAL LLC | 1,693,162 | $40,467,000 | 2.47% |
| Sand Grove Capital Management LLP | 992,068 | $23,710,000 | 2.31% |
| EMC Capital Management | 121,023 | $2,892,000 | 2.06% |
| OMNI PARTNERS LLP | 1,540,671 | $36,822,000 | 1.82% |
| TIG Advisors, LLC | 1,774,849 | $42,419,000 | 1.60% |
| Cowen Prime Services LLC | 174,850 | $4,179,000 | 1.58% |
| G2 Investment Partners Management LLC | 396,400 | $9,474,000 | 1.50% |